Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,020.00    92.00 (2.34%)
Bid:
4,016.00
Ask:
4,018.00
Spread: 2.00 (0.05%)
Market Cap: £15.18b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Director/PDMR Shareholding

7 Sep 2010 17:53

RNS Number : 3142S
Halma PLC
07 September 2010
 



HALMA p.l.c.

 

DIRECTORS' AND PDMR'S SHARE TRANSACTIONS

 

 

Halma has received notifications in respect of Adam Meyers and Neil Quinn, Directors, and John Campbell, PDMR, relating to their beneficial interests in the ordinary shares of the Company.

 

Adam Meyers and John Campbell have beneficial interests held through the Halma Holdings Inc. Profit Sharing Savings Retirement Plan (the 'Plan'). This is a unitised, US Dollar denominated 401(k) plan and dividends paid on the Plan's assets are re-invested for the benefit of members. As a result of the final dividend paid by the Company on 25 August 2010 at the rate of 5.19p per share, the interests held by each of them increase as follows:

 

 

ADAM MEYERS

 

Shares acquired as a result of the Plan dividend re-investment

Increased holding through the Plan

 

 

 

95

 5,012

 

 

In addition to the above, Adam Meyers also has a direct beneficial interest in Halma ordinary shares. After the above transaction, the total beneficial holding of Adam Meyers in the ordinary shares of the Company increases to 182,892 shares (0.0485% of the issued ordinary share capital excluding treasury shares).

 

 

 

JOHN CAMPBELL

 

Shares acquired as a result of the Plan dividend re-investment

Increased holding through the Plan

 

 

 

 

238

12,623

 

 

In addition to the above, John Campbell also has a direct beneficial interest in Halma ordinary shares. After the above transaction, the beneficial holding of John Campbell, including family interests, in the ordinary shares of the Company increases to 144,865 shares (0.0384% of the issued ordinary share capital excluding treasury shares).

 

 

NEIL QUINN

 

At a Meeting of the Share Plans Committee of the Board of Halma p.l.c. held on 07 September 2010, 63,800 additional ordinary shares in the Company were allotted under the provisions of the Company's Share Option Plans to Neil Quinn, a Director, following his exercise of a share option. The exercise price was 163.50 pence per share.

Following the share option exercise Neil Quinn sold 63,800 shares on 07 September 2010 at 281.4365 pence per share. After the above transactions, the beneficial holding of Neil Quinn, including family interests, in the ordinary shares of Halma p.l.c. remains at 218,689 shares (0.0580% of the issued ordinary share capital).

 

Following the issue of ordinary shares as a result of the share options exercised on 07 September 2010, the issued ordinary share capital of the Company, excluding treasury shares, increases to 376,931,518 shares.

 

 

 

For further information, please contact:

 

Andrew Williams +44 (0)1494 721111 Chief Executive, Halma p.l.c.

 

 

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQDLFBBKFEBBF
Date   Source Headline
15th Nov 20217:00 amRNSDirectorate Change
15th Oct 20211:06 pmRNSDirector/PDMR Shareholding
4th Oct 20212:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:01 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading update
9th Sep 202110:22 amRNSDirector Declaration
9th Aug 20217:00 amRNSM&A Update
26th Jul 202111:01 amRNSDirector/PDMR Shareholding
22nd Jul 20213:00 pmRNSResult of AGM
5th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jun 20211:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:47 pmRNSAnnual Financial Report
10th Jun 20217:01 amRNSUnaudited restated segmental information
10th Jun 20217:00 amRNSFull Year Results 2021
27th Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSAppointment of independent non-executive Director
24th Mar 20217:00 amRNSTrading update
23rd Feb 20217:54 amRNSDirector Declaration
10th Feb 20214:52 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSDirectorate Change
21st Dec 20202:00 pmRNSAcquisition
18th Dec 20207:00 amRNSDisposal
4th Dec 20207:04 amRNSDirector Declaration
2nd Dec 20204:08 pmRNSDirector/PDMR Shareholding
25th Nov 20203:20 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSHALF YEAR RESULTS 2020/21
5th Oct 20201:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:05 amRNSDirector Declaration
23rd Sep 20207:00 amRNSChair retirement
23rd Sep 20207:00 amRNSTrading update
4th Sep 20204:57 pmRNSResult of AGM
31st Jul 20204:06 pmRNSDirector/PDMR Shareholding
24th Jul 20205:02 pmRNSAnnual Financial Report
17th Jul 20209:32 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSFinal Results
15th May 20201:29 pmRNSElectronic Communications with Shareholders
27th Apr 202012:46 pmRNSDisclosure of Rights Attached to Equity Shares
21st Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20207:05 amRNSExecutive Board changes
19th Mar 20207:00 amRNSTrading Statement
5th Mar 20209:00 amRNSInvestor Event
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSAcquisition
5th Feb 20207:00 amRNSAcquisition
27th Jan 20207:00 amRNSAcquisition
22nd Jan 202012:58 pmRNSChange of Remuneration Committee Chair
29th Nov 20191:27 pmRNSDirector/PDMR Shareholding
25th Nov 20195:10 pmRNSDirector/PDMR Shareholding
19th Nov 201911:45 amRNSDividend Declaration
19th Nov 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.